Nuclide Therapeutics, a King’s College London spinout developing radioactive drugs to target therapy-resistant cancers, has closed a £5 million ($6.7 million) seed fundraising round led by German ...
The Korea Atomic Energy Research Institute says it has developed a new concept for the world's first nuclide separation device that employs robots and sensors. (Image: KAERI) In order to safely manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback